Security record · archived quarter
AVIR
Atea Pharmaceuticals, Inc. · Healthcare · Biotechnology
8Tracked holders
0Δ holders
4.57MShares held
$15.30MReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -2.9% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 62 | -4 | 39.30M | $182.78M | +3 | −7 |
| Q1 2026 | 68 | +5 | 39.11M | $209.92M | +8 | −3 |
| Q4 2025 | 63 | +1 | 37.55M | $134.03M | +1 | — |
| Q3 2025 | 17 | +2 | 27.75M | $80.49M | +2 | — |
| Q2 2025 | 12 | 0 | 25.41M | $91.49M | +1 | −1 |
| Q1 2025 | 9 | -1 | 6.11M | $18.26M | — | −1 |
| Q4 2024 | 10 | +1 | 6.07M | $20.35M | +2 | −1 |
| Q3 2024 | 8 | 0 | 4.57M | $15.30M | +1 | −1 |
| Q2 2024 | 8 | — | 4.70M | $15.57M | — | — |
Who holds it · Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.92M | -4.2% | $6.45M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.92M | -4.2% | $6.45M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 1.21M | +5.8% | $4.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 595.25K | +13.2% | $1.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 595.25K | +13.2% | $1.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 341.76K | -8.9% | $1.14M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 221.56K | -13.2% | $742,233 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 221.56K | -13.2% | $742,233 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 193.58K | +30.9% | $648,486 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 193.58K | +30.9% | $648,486 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 70.00K | +5.0% | $235,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 13.14K | New | $44,029 | 0.0% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 13.14K | New | $44,029 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| AQR Capital Management | $44,029 | 0.0% |
| AQR Capital Management | $44,029 | 0.0% |
Exited
| Marshall Wace | $603,499 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 126 holders, 59.16M shares, $308.71M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2024 ·
Methodology ·
Get this via the API